Monica Notarbartolo - Concepedia

Author

Monica Notarbartolo

University of Palermo ORCID

Also Known As

M NOTARBARTOLO, M Notarbartolo, M. NOTARBARTOLO, M. Notarbartolo, MONICA NOTARBARTOLO, Monica Notarbartolo

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Palermo Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy National Research Council Instituto Andaluz de Ciencias de la Tierra Universidad de Granada

About

Monica Notarbartolo is an author at University of Palermo specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	971
2	Engineering	3	3	61
3	Biochemistry	3	3	80
4	Health Sciences	2	2	44
5	Natural Sciences	2	2	56

Monica Notarbartolo

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression Monica Notarbartolo, Paola Poma, Daniela Perri, Cancer Letters Iap Gene ExpressionOncogenic AgentMedicinePharmacologyPathology	2005	318
Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) Monica Notarbartolo, Melchiorre Cervello, Luisa Dusonchet, Cancer Letters Possible RelationshipSignal TransductionMedicineReceptor Tyrosine KinaseApoptosis	2002	91
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells Daniele Simoni, Michele Rizzi, Riccardo Rondanin, Bioorganic & Medicinal Chemistry Letters Tumor BiologyMedicinal ChemistryOncologyMedicineβ-Diketone Modified Analogs	2007	87
Expression of the IAPs in multidrug resistant tumor cells Monica Notarbartolo, Melchiorre Cervello, Paola Poma, Oncology Reports	2004	69
The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis Paola Poma, Monica Notarbartolo, Manuela Labbozzetta, International Journal of Molecular Medicine	2007	67
Curcumin as a Possible Lead Compound against Hormone‐Independent, Multidrug‐Resistant Breast Cancer Manuela Labbozzetta, Monica Notarbartolo, Paola Poma, Annals of the New York Academy of Sciences	2009	59
Circulating IL‐6 and sIL‐6R in Patients with Hepatocellular Carcinoma Lydia Giannitrapani, Melchiorre Cervello, Maurizio Soresi, Annals of the New York Academy of Sciences	2002	59
Induction of Apoptosis and Inhibition of Cell Growth in Human Hepatocellular Carcinoma Cells by COX‐2 Inhibitors Daniela Foderà, Natale D’Alessandro, Antonella Cusimano, Annals of the New York Academy of Sciences	2004	58
NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers Paola Poma, Manuela Labbozzetta, Natale D’Alessandro, OMICS A Journal of Integrative Biology Breast OncologyChemoprevention StrategyImmunologyTnbc Cell LinesCancer Biology	2017	56
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities Manuela Labbozzetta, Riccardo Baruchello, Paolo Marchetti, Chemico-Biological Interactions Medicinal ChemistryPyrazole DiketoneMedicineNucleophilic AdditionChemosensitizing Activities	2009	54

Page 1